PHARMACOKINETICS OF CEFETAMET (RO-15-8074) AND CEFETAMET PIVOXIL (RO-15-8075) AFTER INTRAVENOUS AND ORAL DOSES IN HUMANS

被引：49

作者：

KOUP, JR

DUBACH, UC

BRANDT, R

WYSS, R

STOECKEL, K

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DEPT CLIN RES,PHARMACOKINET,CH-4002 BASEL,SWITZERLAND

[2] F HOFFMANN LA ROCHE & CO LTD,DEPT PHARMACEUT RES,PRECLIN DEV,CH-4002 BASEL,SWITZERLAND

[3] UNIV BASEL,HOP CANTONAL,MED OUTPATIENT DEPT,THERAPEUT INVEST STN,CH-4051 BASEL,SWITZERLAND

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 04期

关键词：

D O I：

10.1128/AAC.32.4.573

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：573 / 579

页数：7

相关论文

共 8 条

[1] CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS
BALANT, L
DAYER, P
AUCKENTHALER, R
[J]. CLINICAL PHARMACOKINETICS, 1985, 10 (02) : 101 - 143
[2] COMPUTATION OF MODEL-INDEPENDENT PHARMACOKINETIC PARAMETERS DURING MULTIPLE DOSING
BAUER, LA
GIBALDI, M
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) : 978 - 979
[3] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION
BENET, LZ
GALEAZZI, RL
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) : 1071 - 1074
[4] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
COCKCROFT, DW
GAULT, MH
[J]. NEPHRON, 1976, 16 (01) : 31 - 41
[5] Gibaldi M., 1982, PHARMACOKINETICS, P445
[6] STOECKEL K, 1983, ASIAN PACIFIC C SERI, V19, P5
[7] THE ABSOLUTE BIOAVAILABILITY OF ORAL CEFUROXIME AXETIL IN MALE AND FEMALE VOLUNTEERS AFTER FASTING AND AFTER FOOD
WILLIAMS, PEO
HARDING, SM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (02) : 191 - 196
[8] INVITRO ACTIVITY OF RO 15-8074 AND RO 19-5247, 2 ORALLY-ADMINISTERED CEPHALOSPORIN METABOLITES
WISE, R
ANDREWS, JM
PIDDOCK, LJV
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 1067 - 1072